Download Free Sample Report

The global Viral Molecular Diagnostics market was valued at US$ 8231.6 million in 2022 and is projected to reach US$ 13120 million by 2029, at a CAGR of 6.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease.
This report aims to provide a comprehensive presentation of the global market for Viral Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Molecular Diagnostics. This report contains market size and forecasts of Viral Molecular Diagnostics in global, including the following market information:
Global Viral Molecular Diagnostics Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
North America, followed by Europe, has the largest market for viral molecular diagnostics due to developed healthcare infrastructure, accessibility and affordability of diagnostic tests for viral infectious diseases in this region.
We has surveyed the Viral Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:

• Hepatitis B Virus (HBV)
• Hepatitis C Virus (HCV)
• Human Immunodeficiency Virus (HIV)
• Human Papillomavirus (HPV)

• Hospitals
• Academics Institutions
• Laboratories
• Others

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

• Key companies Viral Molecular Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
• Key companies Viral Molecular Diagnostics revenues share in global market, 2022 (%)

• Abbott Laboraories
• Bio-Rad Laboratories
• Becton, Dickinson
• Roche
• Gen-Probe
• Qiagen
• Olympus
• Thermo Fisher Scientific

Chapter 1: Introduces the definition of Viral Molecular Diagnostics, market overview.
Chapter 2: Global Viral Molecular Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Viral Molecular Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Viral Molecular Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.